Birnam Oak Advisors, LP Verona Pharma PLC Transaction History
Birnam Oak Advisors, LP
- $435 Billion
- Q3 2025
A detailed history of Birnam Oak Advisors, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Birnam Oak Advisors, LP holds 277,604 shares of VRNA stock, worth $29.7 Million. This represents 6.8% of its overall portfolio holdings.
Number of Shares
277,604Holding current value
$29.7 Million% of portfolio
6.8%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
273Shares Held
77.1MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...